Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment

Summary.  In a case of massive bleeding, the possibility of puncturing the joint can be considered to reduce the total load of intra‐articular blood, and thus the total load of iron which, in time, can be found in the synovium with devastating long‐term effects. Subsequent initiation of prophylaxis, still very early in life, might be more beneficial for the preservation of joints. Thus, it might be argued that the initiation of primary prophylaxis should be based on joint haemorrhage history rather than age and, according to some authors, preferably after the bleed in a single joint. The high cost of recombinant factor VIII may make widespread acceptance of prophylaxis impractical. Thus, beneficial results should be balanced with cost considerations. In this balance of treatment cost and efficacy, it must be taken into account that improperly treated haemophilia patients make great demands on healthcare systems (in terms of costs) because of their need for additional treatments such as expensive joint replacement surgery. However, where resources are limited, it can be argued that prophylaxis may be stopped in adulthood, in a certain proportion of all adult patients, with acceptable consequences for orthopaedic outcome in the long term. By doing so, limited amounts of clotting factor can be used for young patients with optimal cost effectiveness.

[1]  H. Hazewinkel,et al.  Very rapid clearance after a joint bleed in the canine knee cannot prevent adverse effects on cartilage and synovial tissue. , 2009, Osteoarthritis and cartilage.

[2]  J. Bijlsma,et al.  55 VERY RAPID CLEARANCE AFTER A JOINT BLEED KNEE CAN NOT PREVENT ADVERSE EFFECTS ON CARTILAGE AND SYNOVIAL TISSUE; A CANINE IN VIVO STUDY , 2008 .

[3]  J. Bijlsma,et al.  Interleukin‐10 protects against blood‐induced joint damage , 2008, British journal of haematology.

[4]  L. Valentino,et al.  The impact of joint bleeding and synovitis on physical ability and joint function in a murine model of haemophilic synovitis , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  N. Goddard,et al.  Diagnosis of haemophilic synovitis , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[7]  C. Manno,et al.  Modern management of haemophilic arthropathy. , 2007, British journal of haematology.

[8]  J. Bijlsma,et al.  Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. , 2007, Arthritis and rheumatism.

[9]  L. Valentino,et al.  Histological changes in murine haemophilic synovitis: a quantitative grading system to assess blood‐induced synovitis , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  K. Fischer,et al.  Can long‐term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands , 2005, British journal of haematology.

[11]  L. Valentino,et al.  Synovitis in a murine model of human factor VIII deficiency , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

[12]  D. Grobbee,et al.  Factor VIII half-life and clinical phenotype of severe hemophilia A. , 2005, Haematologica.

[13]  J. Bijlsma,et al.  Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy. , 2004, Arthritis and rheumatism.

[14]  L. Valentino,et al.  Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[15]  J. Bijlsma,et al.  Short-term exposure of cartilage to blood results in chondrocyte apoptosis. , 2003, The American journal of pathology.

[16]  J. Bijlsma,et al.  Blood-induced joint damage: longterm effects in vitro and in vivo. , 2003, The Journal of rheumatology.

[17]  L. Valentino,et al.  c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. , 2002, Blood.

[18]  D. Grobbee,et al.  The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. , 2002, Blood.

[19]  D. Grobbee,et al.  Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[20]  J. Bijlsma,et al.  Articular cartilage is more susceptible to blood induced damage at young than at old age. , 2000, The Journal of rheumatology.

[21]  J. Bijlsma,et al.  Blood-induced joint damage: a human in vitro study. , 1999, Arthritis and rheumatism.

[22]  J. Bijlsma,et al.  Blood-induced joint damage: a canine in vivo study. , 1999, Arthritis and rheumatism.

[23]  J. Bijlsma,et al.  Synovium in haemophilic arthropathy , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[24]  J. Bijlsma,et al.  Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. , 1998, The Journal of bone and joint surgery. British volume.

[25]  Rodríguez-Merchán Ec Pathogenesis, early diagnosis, and prophylaxis for chronic hemophilic synovitis. , 1997 .

[26]  J. Bijlsma,et al.  Cartilage damage as a result of hemarthrosis in a human in vitro model. , 1997, The Journal of rheumatology.

[27]  E. Rodríguez‐Merchán Pathogenesis, early diagnosis, and prophylaxis for chronic hemophilic synovitis. , 1997, Clinical orthopaedics and related research.

[28]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.

[29]  M. Blombäck,et al.  Prophylaxis with factor concentrates in preventing hemophilic arthropathy. , 1991, The American journal of pediatric hematology/oncology.